You can find our latest news below
With effect from October 2019, Karen has been the North America Sales Manager of HyTest.
Our researchers wrote an editorial for a Clinical Chemistry article
addressing an important but poorly studied interrelationship between
obesity and natriuretic peptide measurements.
We will be attending Medica 2019 in November.
We are delighted to introduce our latest team member, CCO Juhana Rauramo.
Using several immunodiagnostic techniques, our researchers investigated in what forms cTnI and cTnT (as components of the troponin complexes) are present in the blood of patients with acute myocardial infarction.
The article describes the development of a novel immunoassay for the quantification of BNP fragments cleaved by neprilysin.
Alzheimer’s disease is a progressive neurodegenerative
disease and the most common cause of dementia.
We provide three in
vitro produced monoclonal antibodies that are specific to human
beta-amyloid 1-42.
23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory
Medicine - EuroMedLab 2019 was held in Barcelona, May 2019.
During our 25th anniversary year in collaboration with EFLM
through the sponsorship of their award, we have had an excellent
opportunity to show our appreciation towards scientific work in the
field of cardiovascular diseases. Read more about our anniversary year
campaign Challenge25 here.
Anti-Müllerian hormone (AMH) is a dimeric glycoprotein that is
produced by granulosa cells in females and it is currently considered to
be the most reliable biomarker for the assessment of ovarian reserve in
women.